half life of bpc 157 peptide bpc-157 oral bioavailability pharmacokinetics study half-life Peptides: FAQs on Bioavailability, Safety, and Clinical Use bpc-157 pharmacokinetics half-life study clears – Ascor Color:Hot Pink Figure 1 from Nicolau

half life of bpc 157 peptide bpc-157 oral bioavailability pharmacokinetics study half-life Peptides: FAQs on Bioavailability, Safety, and Clinical Use bpc-157 pharmacokinetics half-life study clears – Ascor Color:Hot Pink Figure 1 from Nicolau

Figure 1 from Nicolau syndrome in an athlete following intra-muscular diclofenac injection. | Semantic Scholar

Australia: The Therapeutic Goods Administration (TGA) classifies unapproved peptides under its Therapeutic Goods Act framework

Ascor

Color:Hot Pink

As of May 2026, BPC-157 isn’t FDA-approved and sits on the FDA’s restricted (Category 2) compounding list, so selling it as a drug or supplement is illegal (source)